Resource Library

A new targeted oral therapy is changing the landscape for people with hormone receptor positive, HER2 negative metastatic breast cancer, offering another option for those whose disease has progressed on prior treatment. This practical session steps through how the treatment works, when it is used and what makes its side effect profile distinct.

This webinar explores contemporary best practice in the treatment of HR+, HER2‑ metastatic and early breast cancer, with a focus on optimising patient outcomes through evidence‑based nursing care.

Are you an enrolled nurse, registered nurse or emerging cancer nurse caring for people affected by breast cancer? You may be interested in learning more about Eli Lilly’s Breast Cancer Education Program and how it can support you and your team to build confidence, strengthen knowledge and upskill in everyday oncology practice

Catch up on key insights about the most common side effects of breast cancer treatment—and why early referral to Allied Health can make all the difference. Learn practical tips to support better recovery and long‑term wellbeing.

This webinar is focus on navigating the metastatic breast cancer treatment landscape, with a focus on optimising patient care with Enhertu (trastuzumab deruxtecan) for HER2-positive and HER2-low metastatic breast cancer.

This webinar covered early breast cancer from Diagnosis to Targeted Therapies. "Absolutely great presentation and I’ve been to many! The content was spot on, Sam was engaging and the slides very well put together"